⌕
State Street SPDR S&P Biotech ETF · XBI · NYSE Arca
A sector position · not Tenet-scored
Compare
$145.28−0.41%At close
$145.28−0.60 (−0.41%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE Arca · USD

XBI Holdings

XBI holds 165 positions as of Nov 12, 2026; the largest are MRNA at 2.7%, SYRE at 1.8% and EXEL at 1.8%.

Sources Fund holdings disclosures Fund disclosuresHoldings as of How we compute thisNot investment advice
Positions
165
as of Nov 12, 2026
Largest holding
MRNA 2.7%
No single stock dominates the fund.
Top-10 share
18.2%
Reasonably spread across its top names.

Weights exclude the cash/collateral sleeve (0.0%).

Largest 100 of 165

#TickerCompanyWeightCumulative · to 92.7%
1MRNAMODERNA INC2.7%
2.7%
2SYRESPYRE THERAPEUTICS INC1.8%
4.4%
3EXELEXELIXIS INC1.8%
6.2%
4TGTXTG THERAPEUTICS INC1.7%
7.9%
5BIIBBIOGEN INC1.7%
9.7%
6AMGNAMGEN INC1.7%
11.4%
7REGNREGENERON PHARMACEUTICALS1.7%
13.1%
8ABBVABBVIE INC1.7%
14.8%
9UTHRUNITED THERAPEUTICS CORP1.7%
16.5%
10ORKAORUKA THERAPEUTICS INC1.7%
18.2%
11GILDGILEAD SCIENCES INC1.7%
19.9%
12NBIXNEUROCRINE BIOSCIENCES INC1.6%
21.6%
13ALKSALKERMES PLC1.5%
23.1%
14VRTXVERTEX PHARMACEUTICALS INC1.5%
24.6%
15BBIOBRIDGEBIO PHARMA INC1.5%
26.1%
16PRAXPRAXIS PRECISION MEDICINES I1.4%
27.6%
17ROIVROIVANT SCIENCES LTD1.4%
29.0%
18TWSTTWIST BIOSCIENCE CORP1.4%
30.4%
19KYMRKYMERA THERAPEUTICS INC1.4%
31.9%
20INCYINCYTE CORP1.4%
33.3%
21NTRANATERA INC1.4%
34.7%
22PTCTPTC THERAPEUTICS INC1.4%
36.0%
23ERASERASCA INC1.4%
37.4%
24KODKODIAK SCIENCES INC1.4%
38.8%
25HALOHALOZYME THERAPEUTICS INC1.4%
40.2%
26INSMINSMED INC1.4%
41.5%
27PTGXPROTAGONIST THERAPEUTICS INC1.3%
42.9%
28PCVXVAXCYTE INC1.3%
44.2%
29BMRNBIOMARIN PHARMACEUTICAL INC1.3%
45.5%
30RYTMRHYTHM PHARMACEUTICALS INC1.3%
46.8%
31KRYSKRYSTAL BIOTECH INC1.3%
48.1%
32RVMDREVOLUTION MEDICINES INC1.3%
49.4%
33CRSPCRISPR THERAPEUTICS AG1.2%
50.6%
34DNTHDIANTHUS THERAPEUTICS INC1.2%
51.8%
35GRALGRAIL INC1.2%
53.0%
36MDGLMADRIGAL PHARMACEUTICALS INC1.1%
54.2%
37CYTKCYTOKINETICS INC1.1%
55.3%
38MIRMMIRUM PHARMACEUTICALS INC1.1%
56.4%
39TVTXTRAVERE THERAPEUTICS INC1.1%
57.6%
40COGTCOGENT BIOSCIENCES INC1.1%
58.7%
41CGONCG ONCOLOGY INC1.1%
59.8%
42CDNACAREDX INC1.1%
60.9%
43TNGXTANGO THERAPEUTICS INC1.0%
61.9%
44VKTXVIKING THERAPEUTICS INC1.0%
62.8%
45RLAYRELAY THERAPEUTICS INC0.9%
63.8%
46ALNYALNYLAM PHARMACEUTICALS INC0.9%
64.7%
47IOVAIOVANCE BIOTHERAPEUTICS INC0.9%
65.6%
48BEAMBEAM THERAPEUTICS INC0.9%
66.4%
49ARWRARROWHEAD PHARMACEUTICALS IN0.9%
67.3%
50ARQTARCUTIS BIOTHERAPEUTICS INC0.8%
68.2%
51RAREULTRAGENYX PHARMACEUTICAL IN0.8%
69.0%
52SRRKSCHOLAR ROCK HOLDING CORP0.8%
69.8%
53DYNDYNE THERAPEUTICS INC0.8%
70.6%
54IMVTIMMUNOVANT INC0.8%
71.3%
55IBRXIMMUNITYBIO INC0.8%
72.1%
56VRDNVIRIDIAN THERAPEUTICS INC0.8%
72.9%
57CELCCELCUITY INC0.8%
73.6%
58IONSIONIS PHARMACEUTICALS INC0.7%
74.4%
59VCELVERICEL CORP0.6%
75.0%
60IRONDISC MEDICINE INC0.6%
75.6%
61SMMTSUMMIT THERAPEUTICS INC0.6%
76.2%
62DNLIDENALI THERAPEUTICS INC0.6%
76.8%
63ADMAADMA BIOLOGICS INC0.6%
77.4%
64RXRXRECURSION PHARMACEUTICALS A0.6%
78.0%
65PVLAPALVELLA THERAPEUTICS INC0.6%
78.6%
66VCYTVERACYTE INC0.6%
79.1%
67BHVNBIOHAVEN LTD0.6%
79.7%
68VERAVERA THERAPEUTICS INC0.6%
80.2%
69AGIOAGIOS PHARMACEUTICALS INC0.6%
80.8%
70PURRHYPERLIQUID STRATEGIES0.5%
81.3%
71REPLREPLIMUNE GROUP INC0.5%
81.9%
72BCRXBIOCRYST PHARMACEUTICALS INC0.5%
82.4%
73XNCRXENCOR INC0.5%
82.9%
74IDYAIDEAYA BIOSCIENCES INC0.5%
83.4%
75ABSIABSCI CORP0.5%
83.9%
76QUREUNIQURE NV0.5%
84.4%
77SRPTSAREPTA THERAPEUTICS INC0.5%
84.9%
78NTLAINTELLIA THERAPEUTICS INC0.5%
85.3%
79CLDXCELLDEX THERAPEUTICS INC0.5%
85.8%
80SLSSELLAS LIFE SCIENCES GROUP I0.5%
86.3%
81NVAXNOVAVAX INC0.5%
86.7%
82ACADACADIA PHARMACEUTICALS INC0.5%
87.2%
83TRAXFIRST TRACKS BIOTHERAPEU W/I0.4%
87.6%
84RCUSARCUS BIOSCIENCES INC0.4%
88.0%
85NKTRNEKTAR THERAPEUTICS0.4%
88.4%
86IMNMIMMUNOME INC0.4%
88.7%
87STOKSTOKE THERAPEUTICS INC0.4%
89.1%
88NRIXNURIX THERAPEUTICS INC0.3%
89.4%
89VIRVIR BIOTECHNOLOGY INC0.3%
89.8%
90ANABANAPTYSBIO INC0.3%
90.1%
91MNKDMANNKIND CORP0.3%
90.4%
92ZBIOZENAS BIOPHARMA INC0.3%
90.7%
93INBXINHIBRX BIOSCIENCES INC0.3%
90.9%
94JBIOJADE BIOSCIENCES INC0.3%
91.2%
95PGENPRECIGEN INC0.3%
91.5%
96ANNXANNEXON INC0.2%
91.7%
97SNDXSYNDAX PHARMACEUTICALS INC0.2%
92.0%
98TYRATYRA BIOSCIENCES INC0.2%
92.2%
99MLYSMINERALYS THERAPEUTICS INC0.2%
92.4%
100ARDXARDELYX INC0.2%
92.7%

What are XBI's top holdings?

XBI's five largest holdings as of Nov 12, 2026 are MRNA at 2.7%, SYRE at 1.8%, EXEL at 1.8%, TGTX at 1.7% and BIIB at 1.7%.

How many holdings are in XBI?

XBI holds 165 positions as of Nov 12, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.